Nexplanon 68 MG implants
Ended Awarded
- Contract number
- SPE2DB25FZG28
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $27,772
Award facts
- Contract value 100% obligated
- $27,772.40 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $27,772.40 to DMS Pharmaceutical Group Inc. for 68 mg Nexplanon implants on August 18, 2025, with an ultimate completion date of September 9, 2025. This firm fixed-price delivery order does not utilize a set-aside designation. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, serves as the prime contractor with no identified subcontractors. Nexplanon is a subdermal contraceptive implant, and this delivery order represents one of multiple pharmaceutical product orders the vendor fulfills for the Defense Logistics Agency's medical supply requirements.
This delivery order operates under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense Logistics Agency valued at $499,999,999 and valid through November 2026. Under this umbrella agreement, the company supplies a comprehensive portfolio of pharmaceutical products to support medical supply needs across Department of Defense healthcare facilities worldwide. The indefinite delivery contract vehicle enables the Defense Logistics Agency to issue firm fixed-price delivery orders for branded and generic prescription drugs, biologics, medical consumables, and specialty medications. DMS Pharmaceutical Group's established role as a critical supplier in the federal pharmaceutical supply chain supports the distribution of prescription drugs and pharmacy services to military health facilities nationwide.
Quick answers
Who was awarded contract SPE2DB25FZG28?
SPE2DB25FZG28 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on August 18, 2025.
How much is contract SPE2DB25FZG28 worth?
The government has obligated $27,772 on SPE2DB25FZG28.
Is contract SPE2DB25FZG28 an order under another contract?
Yes. SPE2DB25FZG28 is a delivery order under SPE2DB22D9205, an indefinite delivery contract.
Was contract SPE2DB25FZG28 competed?
The extent of competition for SPE2DB25FZG28 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award